Sign In
Buy PRPH
$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
ProPhase Labs to Present at the Q4 Investor Summit Conference
08:30am, Wednesday, 10'th Nov 2021
GARDEN CITY, NY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the
GARDEN CITY, NY, Nov. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, will hold a conference call on Friday, November 12, 2021 at 11:00 a.
As Employer Vaccine Mandates Fail, Prophase Labs Could Benefit
11:52am, Wednesday, 20'th Oct 2021
As Employer Vaccine Mandates Fail, Prophase Labs Could Benefit
ProPhase Labs Provides Business Update
08:30am, Wednesday, 13'th Oct 2021
Garden City, NY, Oct. 13, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announces that it expects its Q3 2021 COVID-19 testing revenues
ProPhase Labs to Present at the LD Micro Main Event Conference
08:30am, Wednesday, 06'th Oct 2021
GARDEN CITY, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting v
ProPhase Labs to Present at Two Upcoming August Conferences
08:30am, Monday, 16'th Aug 2021
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to pres
ProPhase Labs' (PRPH) CEO Ted Karkus on Q2 2021 Results - Earnings Call Transcript
07:08am, Saturday, 14'th Aug 2021
ProPhase Labs' (PRPH) CEO Ted Karkus on Q2 2021 Results - Earnings Call Transcript
ProPhase Labs Announces Financial Results for the Quarter Ended June 30, 2021
08:11am, Friday, 13'th Aug 2021
Company Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021 at
ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021
08:30am, Monday, 12'th Jul 2021
GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announced that
ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants
02:18pm, Monday, 28'th Jun 2021
There is concern that new Covid-19 variants are spreading and that they have the possibility to escape current vaccinations.
ProPhase Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries
08:30am, Thursday, 10'th Jun 2021
ProPhase Precision Medicine, Inc. and ProPhase Global Healthcare , Inc. to Expand Opportunities in Genomics and International Testing Services
ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference
08:30am, Friday, 28'th May 2021
CEO Ted Karkus to Present at Conference on Thursday , June 10 th , 2021
ProPhase Labs' (PRPH) CEO Ted Karkus on Q1 2021 Results - Earnings Call Transcript
09:18pm, Thursday, 13'th May 2021
ProPhase Labs' (PRPH) CEO Ted Karkus on Q1 2021 Results - Earnings Call Transcript
PRPH Stock: 14.94% Increase (From $5.22 To $6) Pre-Market Explanation
09:02am, Thursday, 06'th May 2021
The stock price of ProPhase Labs Inc (NASDAQ: PRPH) increased 14.94% (from $5.22 to $6) pre-market. This is why it happened.
